High Omega-3 Diet Reduces Cancer Proliferation Marker by 15%
A groundbreaking clinical trial reveals a potential dietary strategy that could transform prostate cancer management for men on active surveillance. The study demonstrates how targeted nutritional intervention may actively slow cancer progression without invasive treatments, offering patients a proactive approach to disease management.
The randomized clinical trial uncovered a remarkable 15% reduction in Ki-67 index—a critical biomarker of cancer cell proliferation—among patients consuming a high omega-3, low omega-6 diet with fish oil supplements. This finding represents a significant breakthrough, providing clinicians with a novel, non-pharmacological tool to delay cancer progression and reduce patient anxiety potentially.
Unlike traditional management strategies, this dietary intervention empowers patients to participate actively in cancer care. The approach offers a low-risk, accessible method to reduce healthcare costs and give men a sense of control during active surveillance. Physicians now have a practical, evidence-based nutritional strategy beyond passive monitoring.
The study’s implications extend beyond individual patient care, suggesting a paradigm shift in how we approach early-stage prostate cancer management. By demonstrating that dietary modifications can potentially influence cancer progression, researchers open new avenues for integrative, patient-centered cancer care.
Reference
Aronson WJ, et al. High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance. Journal of Clinical Oncology. 2024;54:JCO.24.00608
